Published in J Biol Chem on March 15, 1993
Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. J Clin Invest (1998) 3.54
An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J Exp Med (1997) 2.10
Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest (1995) 1.76
Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells. Clin Exp Immunol (1995) 1.61
Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth. Infect Immun (2002) 1.54
Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med (1994) 1.49
Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice. Arthritis Res Ther (2013) 1.49
Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors. Biochem J (2000) 1.36
Selective recruitment of CCR6-expressing cells by increased production of MIP-3 alpha in rheumatoid arthritis. Clin Exp Immunol (2001) 1.30
Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model. J Clin Invest (1998) 1.30
Endogenous retinoids in the pathogenesis of alopecia areata. J Invest Dermatol (2012) 1.28
Synovial microparticles from arthritic patients modulate chemokine and cytokine release by synoviocytes. Arthritis Res Ther (2005) 1.28
Modulation of RANTES production by human cytomegalovirus infection of fibroblasts. J Virol (1997) 1.25
Expression of the chemokine superfamily in rheumatoid arthritis. Clin Exp Immunol (1994) 1.22
Chemokines in joint disease: the key to inflammation? Ann Rheum Dis (2004) 1.20
Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8. Arthritis Res (2001) 1.18
Identification of signaling components required for the prediction of cytokine release in RAW 264.7 macrophages. Genome Biol (2006) 1.14
Chemokines and chemokine receptors in arthritis. Front Biosci (Schol Ed) (2010) 1.06
Interferon gamma induces differential upregulation of alpha and beta chemokine secretion in colonic epithelial cell lines. Gut (1998) 1.06
Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther (2010) 1.02
Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors. Ann Rheum Dis (2004) 1.01
The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis. Rheumatol Int (2004) 0.99
Kinetics of transcription factors regulating the RANTES chemokine gene reveal a developmental switch in nuclear events during T-lymphocyte maturation. Mol Cell Biol (1996) 0.99
Expression of RANTES in human airway epithelial cells: effect of corticosteroids and interleukin-4, -10 and -13. Immunology (1996) 0.99
T Cell Migration in Rheumatoid Arthritis. Front Immunol (2015) 0.98
Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases. Clin Exp Immunol (2001) 0.95
Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization. Angiogenesis (2011) 0.94
Mycoplasma arthritidis-derived superantigen induces proinflammatory monokine gene expression in the THP-1 human monocytic cell line. Infect Immun (1994) 0.92
Requirements for measles virus induction of RANTES chemokine in human astrocytoma-derived U373 cells. J Virol (1999) 0.92
Chemokine expression by subchondral bone marrow stromal cells isolated from osteoarthritis (OA) and rheumatoid arthritis (RA) patients. Clin Exp Immunol (1999) 0.91
The role of cytokines, adhesion molecules, and chemokines in interleukin-2-induced lymphocytic infiltration in C57BL/6 mice. J Clin Invest (1996) 0.90
Interleukin-18, interferon-gamma, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease. Am J Pathol (1999) 0.89
Transcriptome analyses in normal prostate epithelial cells exposed to low-dose cadmium: oncogenic and immunomodulations involving the action of tumor necrosis factor. Environ Health Perspect (2008) 0.88
Synergistic upregulation of interleukin-8 secretion from pulmonary epithelial cells by direct and monocyte-dependent effects of respiratory syncytial virus infection. J Virol (2000) 0.87
Tenidap decreases IL-8 and monocyte chemotactic peptide-1 (MCP-1) mRNA expression in the synovial tissue of rabbits with antigen arthritis and in cultured synovial cells. Clin Exp Immunol (1998) 0.84
Expression of CC and CXC chemokines and chemokine receptors in human leprosy skin lesions. Clin Exp Immunol (2003) 0.83
RANTES and fibroblast growth factor 2 in jawbone cavitations: triggers for systemic disease? Int J Gen Med (2013) 0.83
IFN-gamma impairs release of IL-8 by IL-1beta-stimulated A549 lung carcinoma cells. BMC Cancer (2008) 0.83
The Fli-1 transcription factor regulates the expression of CCL5/RANTES. J Immunol (2014) 0.82
RANTES deficiency attenuates autoantibody-induced glomerulonephritis. J Clin Immunol (2010) 0.82
Interleukin 4 in systemic sclerosis: not just an increase. Clin Diagn Lab Immunol (1999) 0.82
Differential effects of protein kinase C inhibitors on chemokine production in human synovial fibroblasts. Br J Pharmacol (1996) 0.81
Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts. Immunology (2014) 0.80
Peripheral blood T4 cell surface CCR5 density as a marker of activity in rheumatoid arthritis treated with anti-CD20 monoclonal antibody. Immunology (2009) 0.79
Validation of dental X-ray by cytokine RANTES - comparison of X-ray findings with cytokine overexpression in jawbone. Clin Cosmet Investig Dent (2014) 0.79
Regulation of MMP-3 expression and secretion by the chemokine eotaxin-1 in human chondrocytes. J Biomed Sci (2011) 0.79
Metabolic syndrome, peripheral vascular disease and coronary artery disease: A concise review. Int J Angiol (2010) 0.78
Leukocyte population dynamics and detection of IL-9 as a major cytokine at the mouse fetal-maternal interface. PLoS One (2014) 0.78
The protein phosphatase inhibitor calyculin A stimulates chemokine production by human synovial cells. Biochem J (1995) 0.77
Regulation of chemokine CCL5 synthesis in human peritoneal fibroblasts: a key role of IFN-γ. Mediators Inflamm (2014) 0.77
The effects of interleukin-18 on rat articular chondrocytes: a study of mRNA expression and protein synthesis of proinflammatory substances. Clin Exp Immunol (2007) 0.75
Chemokines and the pathogenesis of T cell-dependent immune responses. Am J Pathol (1996) 0.75
Chemokine RANTES/CCL5 as an unknown link between wound healing in the jawbone and systemic disease: is prediction and tailored treatments in the horizon? EPMA J (2015) 0.75
Peripheral Neuropathic Facial/Trigeminal Pain and RANTES/CCL5 in Jawbone Cavitation. Evid Based Complement Alternat Med (2015) 0.75
Identification of a major co-receptor for primary isolates of HIV-1. Nature (1996) 23.81
A new class of membrane-bound chemokine with a CX3C motif. Nature (1997) 7.87
Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell (1997) 6.70
Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell (1993) 4.93
Tumour necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature (1992) 4.57
Chemokine receptors: gateways to inflammation and infection. Nat Med (1996) 3.56
RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med (1992) 3.25
Lymphotactin: a cytokine that represents a new class of chemokine. Science (1994) 2.74
Activation of dual T cell signaling pathways by the chemokine RANTES. Science (1995) 2.65
Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha. J Immunol (1997) 2.51
Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci U S A (1999) 2.51
CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med (1997) 2.24
Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not RANTES or transforming growth factor-beta 1 mRNA expression in acute lung inflammation. Am J Respir Cell Mol Biol (1994) 1.99
Plasma creatinine determination in mice and rats: an enzymatic method compares favorably with a high-performance liquid chromatography assay. Kidney Int (2006) 1.79
Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem (1993) 1.77
Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor. Blood (1994) 1.72
Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J Biol Chem (1997) 1.66
C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. Role for G proteins. J Immunol (1994) 1.66
CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T cell differentiation. J Immunol (1998) 1.64
Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells. Clin Exp Immunol (1995) 1.61
HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines. J Biol Chem (1999) 1.57
Interleukin-16 or not? Nature (1996) 1.56
Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. Proc Natl Acad Sci U S A (1999) 1.53
Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene. J Virol (1998) 1.52
Molecular cloning and functional characterization of human lymphotactin. J Immunol (1995) 1.50
Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med (1994) 1.49
Characterization of Gas6, a member of the superfamily of G domain-containing proteins, as a ligand for Rse and Axl. J Biol Chem (1996) 1.47
Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. J Immunol (1994) 1.39
Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J Immunol (1995) 1.38
Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J Immunol (2000) 1.38
Proton NMR assignments and solution conformation of RANTES, a chemokine of the C-C type. Biochemistry (1995) 1.38
RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J Immunol (1992) 1.36
Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. J Immunol (1995) 1.33
Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor. J Biol Chem (1995) 1.31
Biologic activities of the murine beta-chemokine TCA3. J Immunol (1994) 1.26
RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations. Hum Gene Ther (1996) 1.24
Chemokines: extracellular messengers for all occasions? Bioessays (1999) 1.23
Uncoupling of early signal transduction events from effector function in human peripheral blood neutrophils in response to recombinant macrophage inflammatory proteins-1 alpha and -1 beta. J Immunol (1993) 1.22
Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK. J Immunol (2000) 1.22
CC chemokines induce the generation of killer cells from CD56+ cells. Eur J Immunol (1996) 1.21
Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes. Blood (1998) 1.20
Pancreatic cancer: value of dual-phase helical CT in assessing resectability. Radiology (1998) 1.18
CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms. Circulation (2007) 1.17
RANTES induces tyrosine kinase activity of stably complexed p125FAK and ZAP-70 in human T cells. J Exp Med (1996) 1.15
The human erythrocyte inflammatory peptide (chemokine) receptor. Biochemical characterization, solubilization, and development of a binding assay for the soluble receptor. Biochemistry (1993) 1.14
Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J Immunol (1993) 1.14
Regulation of chemokine gene expression in human peripheral blood neutrophils phagocytosing microbial pathogens. J Immunol (1998) 1.14
The isolation and sequence of a novel gene from a human functional T cell line. J Exp Med (1987) 1.14
Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype. Br J Haematol (1995) 1.14
Engagement of major histocompatibility complex class II molecules by superantigen induces inflammatory cytokine gene expression in human rheumatoid fibroblast-like synoviocytes. J Exp Med (1992) 1.09
Integrin receptors and RGD sequences in human keratinocyte migration: unique anti-migratory function of alpha 3 beta 1 epiligrin receptor. J Invest Dermatol (1992) 1.08
Local expression of inflammatory cytokines in human atherosclerotic plaques. J Atheroscler Thromb (1994) 1.08
Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells. Cell Death Differ (2009) 1.07
Expression and activity of prostaglandin endoperoxide synthase-2 in agonist-activated human neutrophils. FASEB J (1998) 1.07
Induction of acute inflammation in vivo by staphylococcal superantigens. II. Critical role for chemokines, ICAM-1, and TNF-alpha. J Immunol (1998) 1.07
Selective inhibition of human neutrophil functional responsiveness by erbstatin, an inhibitor of tyrosine protein kinase. Blood (1990) 1.07
Differential expression of two major cytokines produced by neutrophils, interleukin-8 and the interleukin-1 receptor antagonist, in neutrophils isolated from the synovial fluid and peripheral blood of patients with rheumatoid arthritis. Arthritis Rheum (1994) 1.06
Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps. J Allergy Clin Immunol (1996) 1.05
Stimulation of human neutrophils by chemotactic factors is associated with the activation of phosphatidylinositol 3-kinase gamma. J Biol Chem (2000) 1.05
Colocalization of cytosolic phospholipase A2, 5-lipoxygenase, and 5-lipoxygenase-activating protein at the nuclear membrane of A23187-stimulated human neutrophils. Eur J Biochem (1996) 1.04
Production of monocyte chemotactic protein-1 in human type B synoviocytes. Synergistic effect of tumor necrosis factor alpha and interferon-gamma. Arthritis Rheum (1993) 1.04
Neuronal expression of fractalkine in the presence and absence of inflammation. FEBS Lett (1998) 1.03
Chemokine receptor CCR3 function is highly dependent on local pH and ionic strength. J Biol Chem (1997) 1.02
Activation of the human neutrophil 5-lipoxygenase by leukotriene B4. Br J Pharmacol (1992) 1.01
Primary sensory neurons migrate in response to the chemokine RANTES. J Neuroimmunol (1998) 1.01
Nuclear signaling in human neutrophils. Stimulation of RNA synthesis is a response to a limited number of proinflammatory agonists. J Biol Chem (1992) 1.01
Modulation by phorbol myristate acetate of arachidonic acid release and leukotriene synthesis by human polymorphonuclear leukocytes stimulated with A23187. Biochem Biophys Res Commun (1986) 1.00
Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Am J Obstet Gynecol (1993) 1.00
Pharmacokinetic and pharmacodynamic evaluation of the novel CCR1 antagonist CCX354 in healthy human subjects: implications for selection of clinical dose. Clin Pharmacol Ther (2011) 0.99
Antibody binding regions on human nerve growth factor identified by homolog- and alanine-scanning mutagenesis. Hybridoma (2000) 0.99
IL-1 activation of endothelium supports VLA-4 (CD49d/CD29)-mediated monocyte transendothelial migration to C5a, MIP-1 alpha, RANTES, and PAF but inhibits migration to MCP-1: a regulatory role for endothelium-derived MCP-1. J Leukoc Biol (1995) 0.99
Differential roles for the p101 and p84 regulatory subunits of PI3Kγ in tumor growth and metastasis. Oncogene (2011) 0.98
Granulocyte/macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophils. J Exp Med (1994) 0.98
Macrophage inflammatory protein-1beta induces migration and activation of human thymocytes. Blood (1998) 0.98
Importance of interleukin-8 in the development of reexpansion lung injury in rabbits. Am J Respir Crit Care Med (2000) 0.97
Genomic organization and biological characterization of the novel human CC chemokine DC-CK-1/PARC/MIP-4/SCYA18. Genomics (1999) 0.96
Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am J Respir Cell Mol Biol (1995) 0.96
Tyrosine phosphorylation in activated human neutrophils. Comparison of the effects of different classes of agonists and identification of the signaling pathways involved. J Immunol (1994) 0.96
Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis. Acta Derm Venereol (1999) 0.95
Identification of G-protein binding sites of the human interleukin-8 receptors by functional mapping of the intracellular loops. FASEB J (1996) 0.95
Chemokines as mediators of allergic inflammation. Int Arch Allergy Immunol (1996) 0.93
Physical association of Gi2alpha with interleukin-8 receptors. J Biol Chem (1996) 0.93
Molecular cloning and functional characterization of a novel member of the C-C chemokine family. J Immunol (1995) 0.93
IL-8-induced signal transduction in T lymphocytes involves receptor-mediated activation of phospholipases C and D. J Immunol (1995) 0.93
Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of adenosine triphosphate or the generation of adenosine. J Biol Chem (1995) 0.92
Overexpression of RANTES using a recombinant adenovirus vector induces the tissue-directed recruitment of monocytes to the lung. J Immunol (1996) 0.92
[Creation and report of the Tunisian Fanconi Anemia Registry (TFAR)]. Arch Pediatr (2012) 0.91
Arachidonic acid-induced mobilization of calcium in human neutrophils: evidence for a multicomponent mechanism of action. Br J Pharmacol (1989) 0.91
Granulocyte-macrophage colony-stimulating factor enhances 5-lipoxygenase levels in human polymorphonuclear leukocytes. J Immunol (1994) 0.91
Regulation of stimulated integrin surface expression in human neutrophils by tyrosine phosphorylation. Blood (1994) 0.91
Characterization of the rhesus cytomegalovirus US28 locus. J Virol (2003) 0.91
Characterization of the priming effects of human granulocyte-macrophage colony-stimulating factor on human neutrophil leukotriene synthesis. Prostaglandins (1988) 0.91